School of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.
J Ethnopharmacol. 2012 Jun 1;141(2):647-52. doi: 10.1016/j.jep.2011.05.019. Epub 2011 May 17.
As a Chinese traditional herbal medicine, leaves of Platycladus orientalis (Linnaeus) Franco (LPO) are used to treat coughs, excessive mucus secretion, chronic bronchitis, bronchiectasis, and asthma, etc. The experiments were carried out to investigate their anti-inflammatory properties and mechanisms, which could support the Chinese traditional uses of treating inflammatory airway diseases.
The anti-inflammatory activities of the chloroform fraction (CHL) and pure compounds of LPO were evaluated for their abilities to inhibit pro-inflammatory enzymes in vitro, and production of tumor necrosis factor-α (TNF-α) and nitric oxide in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Furthermore, the arachidonic acid metabolites, stimulated by calcium ionophore A23187, were also determined by HPLC.
For the first time, the assays of eicosanoids in intact cells showed that the CHL, hinokiol, and acacetin had significant inhibitory effects on 5-hydroxy-eicosa-tetra-enoic acid (5-HETE) and leukotriene B(4) (LTB4) formations. And cell-free enzyme assays (5-lipoxygenase, leukotriene A(4)-hydrolase, cyclooxgenase-2) demonstrated the potent inhibitory effects of the CHL, hinokiol and acacetin on 5-lipoxygenase (5-LOX). Then, the inhibitions of the CHL, hinokiol on NO biosynthesis and the inhibitions of the CHL, 8(14),15-pimaradien-3β,18-diol, and hinokiol on TNF-α release were also confirmed in the RAW264.7 murine macrophages.
The data indicate that the inhibitory effects of the CHL and its components (hinokiol and acacetin) on 5-LOX contribute to the anti-inflammatory activity of LPO. Moreover, the CHL and its components also show beneficial effects on NO and TNF-α production. Consequently, these results provide a rationale for LPO's traditional applications in the treatment of inflammatory airway diseases.
作为中国传统草药,侧柏叶(柏科)用于治疗咳嗽、过多的黏液分泌、慢性支气管炎、支气管扩张和哮喘等疾病。进行这些实验是为了研究其抗炎特性和机制,这可以支持用其治疗炎症性气道疾病的传统用途。
评估了侧柏叶的氯仿部分(CHL)和纯化合物的抗炎活性,以评估它们抑制体外促炎酶的能力,以及脂多糖(LPS)刺激 RAW 264.7 巨噬细胞中肿瘤坏死因子-α(TNF-α)和一氧化氮(NO)的产生。此外,还通过 HPLC 测定了钙离子载体 A23187 刺激的花生四烯酸代谢物。
首次在完整细胞中进行的类二十烷酸分析表明,CHL、柏木脑和芹菜素对 5-羟基二十碳四烯酸(5-HETE)和白三烯 B4(LTB4)的形成具有显著的抑制作用。并且细胞游离酶分析(5-脂氧合酶、白三烯 A4-水解酶、环氧化酶-2)表明 CHL、柏木脑和芹菜素对 5-脂氧合酶(5-LOX)具有很强的抑制作用。然后,在 RAW264.7 鼠巨噬细胞中还证实了 CHL、柏木脑对 NO 生物合成的抑制作用以及 CHL、8(14),15-松脂二烯-3β,18-二醇和柏木脑对 TNF-α释放的抑制作用。
数据表明,CHL 及其成分(柏木脑和芹菜素)对 5-LOX 的抑制作用有助于侧柏叶的抗炎活性。此外,CHL 及其成分对 NO 和 TNF-α 的产生也有有益的影响。因此,这些结果为侧柏叶在治疗炎症性气道疾病中的传统应用提供了依据。